133 related articles for article (PubMed ID: 29484186)
41. Systemic antibody responses induced by a two-component Clostridium difficile toxoid vaccine protect against C. difficile-associated disease in hamsters.
Anosova NG; Brown AM; Li L; Liu N; Cole LE; Zhang J; Mehta H; Kleanthous H
J Med Microbiol; 2013 Sep; 62(Pt 9):1394-1404. PubMed ID: 23518659
[TBL] [Abstract][Full Text] [Related]
42. Lysionotin attenuates Staphylococcus aureus pathogenicity by inhibiting α-toxin expression.
Teng Z; Shi D; Liu H; Shen Z; Zha Y; Li W; Deng X; Wang J
Appl Microbiol Biotechnol; 2017 Sep; 101(17):6697-6703. PubMed ID: 28710557
[TBL] [Abstract][Full Text] [Related]
43. Heterogeneous early immune responses to the S. aureus EapH2 antigen induced by gastrointestinal tract colonisation impact the response to subsequent vaccination.
Flaxman A; Yamaguchi Y; van Diemen PM; Rollier C; Allen E; Elshina E; Wyllie DH
Vaccine; 2019 Jan; 37(3):494-501. PubMed ID: 30503080
[TBL] [Abstract][Full Text] [Related]
44. No evident association of nasal carriage of Staphylococcus aureus or its small-colony variants with cotrimoxazole use or ANCA-associated vasculitis relapses.
Tan BK; Crabol Y; Tasse J; Laurent F; Nekkab N; Vinter C; Puéchal X; Guillevin L
Rheumatology (Oxford); 2020 Jan; 59(1):77-83. PubMed ID: 31834404
[TBL] [Abstract][Full Text] [Related]
45. Oral administration of cholera toxin-Sendai virus conjugate potentiates gut and respiratory immunity against Sendai virus.
Liang XP; Lamm ME; Nedrud JG
J Immunol; 1988 Sep; 141(5):1495-501. PubMed ID: 2842395
[TBL] [Abstract][Full Text] [Related]
46. Characteristics of toxin-neutralization by anti-tetanus human monoclonal antibodies directed against the three functional domains [A], [B] and [C] of the tetanus toxin molecule and a reliable method for evaluating the protective effects of monoclonal antibodies.
Matsuda M; Kamei M; Sugimoto N; Ma Y; Hashizume S
Eur J Epidemiol; 1992 Jan; 8(1):1-8. PubMed ID: 1572415
[TBL] [Abstract][Full Text] [Related]
47. Effects of subinhibitory concentrations of antibiotics on alpha-toxin (hla) gene expression of methicillin-sensitive and methicillin-resistant Staphylococcus aureus isolates.
Ohlsen K; Ziebuhr W; Koller KP; Hell W; Wichelhaus TA; Hacker J
Antimicrob Agents Chemother; 1998 Nov; 42(11):2817-23. PubMed ID: 9797209
[TBL] [Abstract][Full Text] [Related]
48. Pharmacokinetics and pharmacodynamics of DSTA4637A: A novel THIOMAB™ antibody antibiotic conjugate against Staphylococcus aureus in mice.
Zhou C; Lehar S; Gutierrez J; Rosenberger CM; Ljumanovic N; Dinoso J; Koppada N; Hong K; Baruch A; Carrasco-Triguero M; Saad O; Mariathasan S; Kamath AV
MAbs; 2016; 8(8):1612-1619. PubMed ID: 27653831
[TBL] [Abstract][Full Text] [Related]
49. Safety and immunogenicity of a respiratory syncytial virus fusion glycoprotein F subunit vaccine in healthy adults: Results of a phase 1, randomized, observer-blind, controlled, dosage-escalation study.
Leroux-Roels G; De Boever F; Maes C; Nguyen TL; Baker S; Gonzalez Lopez A
Vaccine; 2019 May; 37(20):2694-2703. PubMed ID: 30987852
[TBL] [Abstract][Full Text] [Related]
50. Efficacy of a Multimechanistic Monoclonal Antibody Combination against Staphylococcus aureus Surgical Site Infections in Mice.
Ortines RV; Wang Y; Liu H; Dikeman DA; Pinsker BL; Miller RJ; Kim SE; Ackerman NE; Rizkallah JF; Marcello LT; Cohen TS; Tkaczyk C; Sellman BR; Miller LS
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31138566
[TBL] [Abstract][Full Text] [Related]
51. A phase 1 study of PAmAb, a fully human monoclonal antibody against Bacillus anthracis protective antigen, in healthy volunteers.
Subramanian GM; Cronin PW; Poley G; Weinstein A; Stoughton SM; Zhong J; Ou Y; Zmuda JF; Osborn BL; Freimuth WW
Clin Infect Dis; 2005 Jul; 41(1):12-20. PubMed ID: 15937757
[TBL] [Abstract][Full Text] [Related]
52. Dracorhodin Perochlorate attenuates Staphylococcus aureus USA300 virulence by decreasing α-toxin expression.
Liu Y; Shi D; Guo Y; Li M; Zha Y; Wang Q; Wang J
World J Microbiol Biotechnol; 2017 Jan; 33(1):17. PubMed ID: 27900629
[TBL] [Abstract][Full Text] [Related]
53. Genetic delivery of an anti-RSV antibody to protect against pulmonary infection with RSV.
Skaricic D; Traube C; De B; Joh J; Boyer J; Crystal RG; Worgall S
Virology; 2008 Aug; 378(1):79-85. PubMed ID: 18556039
[TBL] [Abstract][Full Text] [Related]
54. Heterologous protection against alpha toxins of Clostridium perfringens and Staphylococcus aureus induced by binding domain recombinant chimeric protein.
Uppalapati SR; Kingston JJ; Murali HS; Batra HV
Vaccine; 2014 May; 32(25):3075-81. PubMed ID: 24699467
[TBL] [Abstract][Full Text] [Related]
55. Chronic nasal Staphylococcus aureus carriage identifies a subset of newly diagnosed granulomatosis with polyangiitis patients with high relapse rate.
Salmela A; Rasmussen N; Tervaert JWC; Jayne DRW; Ekstrand A;
Rheumatology (Oxford); 2017 Jun; 56(6):965-972. PubMed ID: 28339745
[TBL] [Abstract][Full Text] [Related]
56. Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial.
Wenzel S; Castro M; Corren J; Maspero J; Wang L; Zhang B; Pirozzi G; Sutherland ER; Evans RR; Joish VN; Eckert L; Graham NM; Stahl N; Yancopoulos GD; Louis-Tisserand M; Teper A
Lancet; 2016 Jul; 388(10039):31-44. PubMed ID: 27130691
[TBL] [Abstract][Full Text] [Related]
57. Staphylococcus Aureus carriage and long-term Rituximab treatment for Granulomatosis with polyangiitis.
Besada E; Koldingsnes W; Nossent JC
PeerJ; 2015; 3():e1051. PubMed ID: 26137431
[TBL] [Abstract][Full Text] [Related]
58. Safety profile and clinical activity of sifalimumab, a fully human anti-interferon α monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study.
Merrill JT; Wallace DJ; Petri M; Kirou KA; Yao Y; White WI; Robbie G; Levin R; Berney SM; Chindalore V; Olsen N; Richman L; Le C; Jallal B; White B;
Ann Rheum Dis; 2011 Nov; 70(11):1905-13. PubMed ID: 21798883
[TBL] [Abstract][Full Text] [Related]
59. Mitoxantrone: a review of its use in multiple sclerosis.
Scott LJ; Figgitt DP
CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
[TBL] [Abstract][Full Text] [Related]
60. Meticillin-resistant Staphylococcus aureus in a veterinary orthopaedic referral hospital: staff nasal colonisation and incidence of clinical cases.
McLean CL; Ness MG
J Small Anim Pract; 2008 Apr; 49(4):170-7. PubMed ID: 18339087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
